NCT06119295Completed
Investigating the Effects of Altering Portion Size Reduction Awareness on Compensatory Eating Behaviour
Source: ClinicalTrials.gov · Last updated 18 Dec 2024
Brief summary (registry, in English)
The present study aims to investigate whether energy intake is reduced when participants consume a reduced portion size (15% compared to the 'control' portion), and also to see whether awareness of this reduction affects energy intake.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 108 (actual)
- First submitted
- 30 Oct 2023
- Start date
- Nov 2023
- Primary completion date
- May 2024
- Lead sponsor
- University of Liverpool
- Diseases
- Obesity
- NCT number
- NCT06119295
What you commit to
- Study type: Interventional
- Participants enrolled: 108
- From Nov 2023 to the primary completion date, May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current medication use which affects appetite
- Currently or previously diagnosed with an eating disorder
- Currently on a diet
Other illness
- Have any food allergies or intolerances
Other
- Pregnant
- Are vegan
Who the study is looking for
- United Kingdom (UK) residents able to visit laboratory on campus in Liverpool, aged ≥ 18
- Body Mass Index (BMI) between 18.5 and 32.5 kg/m2
- Proficiency in English language
- Self-report willingness to eat each of the test foods
Age in the registry: 18 years to 60 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Liverpool Coordinator of this site? Confirm its status | Liverpool | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.